Pacific Edge shares tumble 14% after FY net loss
Wednesday, 29 May 2019, 2:21 pm
By Rebecca Howard
May 29 (BusinessDesk) - Pacific
Edge's shares fell 14 percent, despite reporting a smaller
full year net loss as more people adopted its Cxbladder
cancer diagnostics tests.
The shares dropped to 18.5 cents
after the Dunedin-based company reported a loss of $17.9
million in the year to March 31, versus a loss of $19.7
million in the prior year. Operating revenue from test sales
was up 12 percent to $3.8 million while total revenue was up
3 percent to $5.1 million.